summary Archives

New Antibody Removes Tregs to Boost Immune Response Against Cancer

Treg play a deleterious role in the tumor microenvironment by suppressing anti-tumor effector T cells."... read more

November 19, 2025

Preclinical and clinical studies indicate that ferroptosis suppresses tumor growth, and dysregulation of ferroptosis promotes... read more

November 6, 2025

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy with poorly characterized molecular... read more

October 22, 2025

In non–small cell lung cancer (NSCLC), alterations in the HER2 (ERBB2) gene define a... read more

October 8, 2025

Heavily pretreated metastatic colorectal cancer (mCRC) poses significant therapeutic challenges."Colorectal cancer is one of... read more

September 24, 2025

Identification and analyses of exceptional responders could eventually offer hints as to why PC is... read more

September 11, 2025

Amivantamab, an anti-EGFR/MET bispecific antibody, shows efficacy in EGFR-mutated NSCLC, but its role in... read more

August 26, 2025

Lung cancer remains the leading cause of cancer-related fatalities in the United States and worldwide,... read more

August 11, 2025

Currently, there is no effective therapy for CRPC."Prostate cancer is the second most diagnosed... read more

July 29, 2025

targeting PRDX1 should sensitize tumours to DNA-damaging agents."Scientists have uncovered a promising new strategy... read more

July 14, 2025